Skeets, Medarex, MEDX, is an immune system manipulation co. that enhances and guides the body's own defences to perform certain activities. They refer to this as killer cells or bispecifics in most cases and they have several products in the clinic that track down breast cancer and leukemia cells and show the body's immune system where to attack. They have partnerships with Merch (German parent, not US spin off -g-) and Ciba-Geigy to develop the products.
Much of what MEDX does is similar to what CEGE does, and CEGE has hit paydirt sooner, though with a different target. However, the market views this as positive for CEGE, which is is, and negative for MEDX, which it isn't. It simply validates the science they are both using. At $5 and change, MEDX is a great bio holding for the risk taker. MB |
